Crossmark

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)

Crossref DOI link: https://doi.org/10.1186/s12885-017-3057-3

Published Online: 2017-02-07

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ray-Coquard, Isabelle

Collard, Olivier

Ducimetiere, Françoise

Laramas, Mathieu

Mercier, Florence

Ladarre, Nadine

Manson, Stephanie

Tehard, Bertrand

Clippe, Sébastien

Suchaud, Jean-Philippe

Stefani, Laetitia

Blay, Jean-Yves
Funding

Funding for this research was provided by:

GlaxoSmithKline

EMD Serono (not done)